Par Pharmaceuticals Pleads Guilty to Civil & Criminal Allegations of Off-Label Marketing

Image Source: Par Pharmaceuticals allegedly committed fraud by promoting Megace ES for off-label uses not approved by the Food and Drug Administration. Par Pharmaceuticals recently pled guilty in federal court  to charges of off-label marketing and will be forced to pay $45 million in order to resolve the company’s criminal and civil liability. [...]

By | 2018-03-26T11:53:12+00:00 March 5th, 2013|Healthcare Fraud|